Deerfield Beach, FL -- (SBWIRE) -- 01/11/2017 -- Nuclear medicine uses radioactive materials to identify and diagnose and treat disease including different types of cancers, heart disease, endocrine, and neurological disorders, among other. Nuclear medicines are primarily used with help of nuclear medicine technologists. It utilizes a radionuclide and uses the process of radioactive decay for the treatment and diagnosis of diseases. The key component of nuclear medicine include radioactive isotopes and radiological imaging devices including magnetic resonance imaging (MRI), positron emission tomography (PET), and single photon emission tomography (SPECT).

Get a copy of free Sample Report @ http://www.syndicatemarketresearch.com/request-for-sample.html?flag=S&repid=87246

The nuclear medicine market is mainly driven by the rising incidence and prevalence of cancer. In addition, growing health awareness, and rising application of SPECT and PET with advancement of technology is expected to trigger the growth of this industry in the coming years. However, stringent regulatory guidelines and shorter half-life of radiopharmaceuticals may pose the challenge to nuclear medicine market. Nonetheless, high demand in emerging markets is expected open new avenues for the market growth over the next few years.

Know more before buying this report @ http://www.syndicatemarketresearch.com/market-analysis/nuclear-medicine-market.html#inquiry-for-buying

This report provides detailed analysis and forecast of the nuclear medicine market on a global and regional level. The report includes detailed competitive landscape of the global nuclear medicine market and an analysis of Porter's five forces model for the nuclear medicine market has also been included. It includes company market share analysis, product portfolio of the major industry participants. The report provides detailed segmentation of the nuclear medicine market based on application and region segment. Key application market for nuclear medicine includes therapeutics and diagnostics. Diagnostics was the leading application segment for nuclear medicine market.

Request for TOC@ http://www.syndicatemarketresearch.com/market-analysis/nuclear-medicine-market.html#table-of-content

Major regional segments analyzed in this study include North America, Europe, Asia Pacific, Latin America, and Middle East and Africa with its further bifurcation into major countries including U.S., Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for nuclear medicine based on individual applications in all the regions and countries. North America dominated nuclear medicine market in 2015 followed by Europe and Asia Pacific.

Browse detail report with in-depth TOC @ http://www.syndicatemarketresearch.com/market-analysis/nuclear-medicine-market.html

The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. Key players profiled in the report include Cardinal Health, Inc., Bracco Imaging S.p.A, IPES, G.E Healthcare, Ashby Gorman Baker Ltd., Mediso Ltd., Pinestar Technology, Inc.,Bayer Healthcare, and Nordion, Inc.

Nuclear medicine Market: Application Segment Analysis
Therapeutics
Thyroid
Bone Metastasis
Lymphoma
Other
Diagnostics
Spect
Pet
Neurology
Cardiovascular
Nephrology
Oncology

Nuclear medicine Market: Regional Segment Analysis

North America
U.S.
Europe
Germany
France
UK
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East And Africa

Contact US:
Joel John
3422 SW 15 Street,Suit #8138
Deerfield Beach,Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803
Email: sales@syndicatemarketresearch.com
Website: http://www.syndicatemarketresearch.com